- Latest available (Revised)
- Point in Time (01/10/2011)
- Original (As made)
Version Superseded: 01/10/2013
Point in time view as at 01/10/2011. This version of this provision has been superseded.
You are viewing this legislation item as it stood at a particular point in time. A later version of this or provision, including subsequent changes and effects, supersedes this version.
Note the term provision is used to describe a definable element in a piece of legislation that has legislative effect – such as a Part, Chapter or section.
There are currently no known outstanding effects for the The Veterinary Medicines Regulations 2011 (revoked), Paragraph 17.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
17.—(1) This paragraph applies in relation to an application for a variation to one or more marketing authorisations except where paragraph 18, 19 or 21 applies.
(2) The fees for the variations to which this paragraph applies are set out in the following table.
(3) Where applications are made at the same time seeking an identical change to the terms of more than one marketing authorisation, and those applications are based on identical data, fees are payable as for a grouped variation.
(4) References in this paragraph to a grouped variation being “led” by a particular type of variation indicate that the principal variation in that group is a variation of that type.
Type of variation | National | UK is the reference Member State | UK is a concerned Member State | |||||
---|---|---|---|---|---|---|---|---|
Single variations; one change for each product | ||||||||
Extension: | ||||||||
Change of strength or potency or the addition of a new strength or potency | 6,670 | - | 3,330 | |||||
Change of pharmaceutical form or the addition of a new pharmaceutical form | 8,415 | - | 3,835 | |||||
Change of route of administration, or the addition of a new one, of— | - | |||||||
(i) an immunological product, or a pharmaceutical product for a non food-producing animal | 5,390 | - | 2,895 | |||||
(ii) a pharmaceutical product for a food-producing animal | 7,135 | - | 3,430 | |||||
Change or addition of target species | 9,620 | - | 4,245 | |||||
Change of active substance | 8,415 | - | 3,835 | |||||
Other | 8,415 | - | 3,835 | |||||
Simultaneous application: fee for each additional product in the application | 2,895 | - | 1,685 | |||||
Type II | 3,135 | 6,030 | 3,120 | |||||
Type IB | 885 | 1,325 | 885 | |||||
Type IA | 455 | 685 | 455 | |||||
Grouped variations | ||||||||
Extension-led: | ||||||||
The fee for an application for an extension-led grouped variation is the fee for that extension as specified above plus — | ||||||||
(a) if there is one variation in addition to the extension, the fee for that variation as specified above; or | ||||||||
(b) if there is more than one variation in addition to the extension, the fee that would be payable for a grouped variation of that type as specified below. | ||||||||
Type II led: | ||||||||
For the first nine changes | 6,280 | 12,060 | 6,280 | |||||
For each subsequent group of up to ten changes | 4,500 | 4,500 | 4,500 | |||||
Type IB led: | ||||||||
For the first nine changes | 1,770 | 2,650 | 1,770 | |||||
For each subsequent group of up to ten changes | 4,500 | 4,500 | 4,500 | |||||
Type IA led: | ||||||||
For the first nine changes | 885 | 1,325 | 885 | |||||
For each subsequent group of up to ten changes | 4,500 | 4,500 | 4,500 |
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: